Upgrading GBM Translational Models for Accelerated Therapeutic Advances

Time: 11:00 am
day: Pre-Conference Workshop Day New


Optimization of patient-derived models, innovations in translational platforms, and strategies to bridge the translational gap.

This workshop will gather experts to discuss:

  • Optimizing patient-derived models for personalized glioblastoma therapies
  • Implementing PDX and organoid models for more effective drug screening and enhancing treatment response prediction with in vitro and in vivo models
  • GBM translational models: Beyond the traditional
  • Exploring advanced 3D and ex vivo culture systems for glioblastoma research, harnessing organ-on-a-chip and microfluidic platforms for high-throughput screening and utilizing patient-derived organoids for modelling tumor heterogeneity and drug resistance
  • Review case studies highlighting successful translation of preclinical findings to clinical trials